First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases

Despite progress in treatment, progressive non-small cell lung cancer (NSCLC) still limits survival dramatically, and novel therapeutic compounds are needed. Initial investigations suggest that artesunate (ART), an antimalarial drug, has antiproliferative capacities. However, antiinvasive and antime...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Rasheed, Suhail Ahmed Kabeer (VerfasserIn) , Efferth, Thomas (VerfasserIn) , Asangani, Irfan A. (VerfasserIn) , Allgayer, Heike (VerfasserIn)
Dokumenttyp:	Article (Journal)
Sprache:	Englisch
Veröffentlicht:	19 July 2010
In:	International journal of cancer Year: 2010, Jahrgang: 127, Heft: 6, Pages: 1475-1485
ISSN:	1097-0215
DOI:	10.1002/ijc.25315
Online-Zugang:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1002/ijc.25315 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.25315
Verfasserangaben:	Suhail Ahmed Kabeer Rasheed, Thomas Efferth, Irfan Ahmed Asangani and Heike Allgayer

First evidence that the anti-malarial drug Artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases von Rasheed, Suhail Ahmed Kabeer (VerfasserIn)

2010

Book/Monograph Hochschulschrift

First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases

First evidence that the anti-malarial drug Artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases von Rasheed, Suhail Ahmed Kabeer (VerfasserIn)

Ähnliche Einträge